ITG (ITG) Stock Looks Undervalued Even As Broader Checks Stay Cautious

ITG stock has slipped around 3.4% year to date, and the early valuation read is mixed, with simple market multiples pointing ...

Oaktree Capital-backed ITG prices below range ahead of Nasdaq debut, raises $312.2M

Oaktree Capital Management-backed digital infrastructure services firm ITG Inc priced its initial public offering below its ...

ITG sets IPO terms: Targets $19 to $22 price range for Nasdaq debut

ITG (ITG) announced the launch of its roadshow for a proposed initial public offering (IPO), offering 19,512,196 shares of ...

ITG, Inc. Announces Closing of Initial Public Offering

ITG, Inc. (Nasdaq: ITG) (“ITG” or the “Company”), a leading provider of end-to-end services to the communications and digital ...

Nine Mile Metals Strengthens Capital Markets Strategy with Market-Making and Global Digital Media Engagements

Nine Mile Metals Ltd. (CSE: NINE) (OTCID: VMSXF) (FSE: KQ9) ("Nine Mile" or the "Company") is pleased to announce that it has ...
Traders Magazine

ITG Courts the Sellside

Investment Technology Group, best known for providing the buyside with electronic trading services, has quietly embraced the sellside. With the drought in orders from money managers now stretching ...
FiercePharma

ITG's Majestic Market Research Prostate Cancer Study Indicates Amgen's Xgeva is Poised to Steal Significant Share From Novartis'

NEW YORK, March 22, 2011 /PRNewswire/ -- A study in the prostate cancer space completed this week by ITG's Majestic Market Research reveals that Amgen's (Nasdaq: AMGN) Xgeva (a.k.a. denosumab, Prolia) ...